Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation

Thrombosis Research

Volumn 124, Issue 1, 2009, Pages 75-79

  Hyun, Jungwon ^a   Kim, Hyun Kyung ^a   Kim, Ji Eun ^a   Lim, Min Gyu ^a   Jung, Jae Seol ^a   Park, Seonyang ^a   Cho, Han Ik ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

A disintegrin like and metalloprotease with thrombospondin type 1 repeats; ADAMTS 13; Coagulopathy; DIC; Disseminated intravascular coagulation; Prognosis; ULvWF; Unusually large von Willebrand factor

Indexed keywords

ANTITHROMBIN; CD64 ANTIGEN; INTERLEUKIN 6; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENERGY TRANSFER; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE;

ADAM PROTEINS; AGED; ANTITHROMBINS; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOTHELIUM, VASCULAR; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; KAPLAN-MEIERS ESTIMATE; KOREA; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE; VON WILLEBRAND FACTOR;

EID: 64649102403     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.11.020     Document Type: Article

References (23)

1. Moake J.L. Thrombotic microangiopathies. N Engl J Med 347 (2002) 589-600
2. Tsai H.M., and Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 (1998) 1585-1594
3. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., Yang A.Y., Siemieniak D.R., Stark K.R., Gruppo R., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 (2001) 488-494
4. Bianchi V., Robles R., Alberio L., Furlan M., and Lammle B. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 100 (2002) 710-713
5. Mannucci P.M., Vanoli M., Forza I., Canciani M.T., and Scorza R. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica 88 (2003) 914-918
6. Mannucci P.M., Canciani M.T., Forza I., Lussana F., Lattuada A., and Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 98 (2001) 2730-2735
7. Reiter R.A., Varadi K., Turecek P.L., Jilma B., and Knobl P. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost 93 (2005) 554-558
8. Martin K., Borgel D., Lerolle N., Feys H.B., Trinquart L., Vanhoorelbeke K., et al. Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 35 (2007) 2375-2382
9. Nguyen T.C., Liu A., Liu L., Ball C., Choi H., May W.S., et al. Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis. Haematologica 92 (2007) 121-124
10. Ono T., Mimuro J., Madoiwa S., Soejima K., Kashiwakura Y., Ishiwata A., et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 107 (2006) 528-534
11. Song S.H., Kim H.K., Park M.H., and Cho H.I. Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation. Thromb Res 121 (2008) 499-507
12. Crawley J.T., Lam J.K., Rance J.B., Mollica L.R., O'Donnell J.S., and Lane D.A. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 105 (2005) 1085-1093
13. Taylor Jr. F.B., Toh C.H., Hoots W.K., Wada H., and Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (2001) 1327-1330
14. Dhainaut J.F., Yan S.B., Joyce D.E., Pettila V., Basson B., Brandt J.T., et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2 (2004) 1924-1933
15. Toh C.H., and Hoots W.K. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 5 (2007) 604-606
16. Bakhtiari K., Meijers J.C., de Jonge E., and Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32 (2004) 2416-2421
17. Dempfle C.E., Wurst M., Smolinski M., Lorenz S., Osika A., Olenik D., et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost 91 (2004) 812-818
18. Reiter R.A., Knobl P., Varadi K., and Turecek P.L. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin. Blood 101 (2003) 946-948
19. Turner N., Nolasco L., Tao Z., Dong J.F., and Moake J. Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost 4 (2006) 1396-1404
20. Levi M., and Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 341 (1999) 586-592
21. Bernardo A., Ball C., Nolasco L., Moake J.F., and Dong J.F. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 104 (2004) 100-106
22. Lam J.K., Chion C.K., Zanardelli S., Lane D.A., and Crawley J.T. Further characterization of ADAMTS-13 inactivation by thrombin. J Thromb Haemost 5 (2007) 1010-1018
23. Liu L., Choi H., Bernardo A., Bergeron A.L., Nolasco L., Ruan C., et al. Platelet-derived VWF-cleaving metalloprotease ADAMTS-13. J Thromb Haemost 3 (2005) 2536-2544